Literature DB >> 12571818

A comparison of GMS-A/AGECAT, DSM-III-R for dementia and depression, including subthreshold depression (SD)--results from the Berlin Aging Study (BASE).

R T Schaub1, M Linden, J R M Copeland.   

Abstract

BACKGROUND: Empirical evaluation of the agreement between different diagnostic approaches is crucial for the understanding of epidemiological results in geriatric psychiatry.
OBJECTIVES: In this paper, we analyse differences between widely used diagnostic approaches of dementia and depression and offer evidence that diagnostic thresholds vary substantially on quantitative dimensions, but that conceptual and other differences between approaches must also been taken into account.
METHODS: In an epidemiological study of n = 516 persons, aged 70-103 years, we compared psychiatric diagnoses of dementia and depression obtained by GMS-A/HAS-AGECAT, DSM-III-R and clinician's diagnoses of subthreshold depression (SD).
RESULTS: For depression, cumulative prevalence of clinician's diagnosis (including SD, GMS-A/HAS-AGECAT and DSM-III-R defined forms) was highest, followed by GMS-A/HAS-AGECAT-diagnosis and DSM-III-R, while for dementia DSM-III-R was followed by GMS-A/HAS-AGECAT. Overall agreement between DSM-III-R and GMS-A/HAS-AGECAT was moderate. Adapting thresholds for AGECAT resulted in slightly better diagnostic efficiency. Diagnostic disagreement was found predominantly for cases with intermediate symptom severity, supporting the hypothesis of differing thresholds between DSM-III-R and GMS-A/HAS-AGECAT, while cases with lower or higher symptom severity were similarly seen as cases or non-cases.
CONCLUSION: Disagreement is not only caused by conceptual differences, but also different thresholds of diagnostic algorithms. Adaptation of threshold levels should be feasible, depending on the purpose of the analysis. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12571818     DOI: 10.1002/gps.799

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

1.  Depression and incident Alzheimer disease: the impact of disease severity.

Authors:  Patricia Gracia-García; Concepción de-la-Cámara; Javier Santabárbara; Raúl Lopez-Anton; Miguel Angel Quintanilla; Tirso Ventura; Guillermo Marcos; Antonio Campayo; Pedro Saz; Constantine Lyketsos; Antonio Lobo
Journal:  Am J Geriatr Psychiatry       Date:  2013-06-20       Impact factor: 4.105

Review 2.  Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.

Authors:  Samuel T Creavin; Anna H Noel-Storr; Ryan J Langdon; Edo Richard; Alexandra L Creavin; Sarah Cullum; Sarah Purdy; Yoav Ben-Shlomo
Journal:  Cochrane Database Syst Rev       Date:  2022-06-16

3.  Validity of the self reporting questionnaire-20 in epidemiological studies with older adults: results from the Sao Paulo Ageing & Health Study.

Authors:  Marcia Scazufca; Paulo R Menezes; Homero Vallada; Ricardo Araya
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-09-08       Impact factor: 4.328

4.  Differences in Trajectories and Predictive Factors of Cognition over Time in a Sample of Cognitively Healthy Adults, in Zaragoza, Spain.

Authors:  Elena Lobo; Patricia Gracia-García; Antonio Lobo; Pedro Saz; Concepción De-la-Cámara
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

5.  A Novel Score for Predicting Alzheimer's Disease Risk from Late Life Psychopathological and Health Risk Factors.

Authors:  Javier Santabárbara; Juan Bueno-Notivol; Darren M Lipnicki; Concepción de la Cámara; Raúl López-Antón; Antonio Lobo; Patricia Gracia-García
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

6.  APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.

Authors:  H A D Keage; F E Matthews; A Yip; L Gao; C McCracken; I G McKeith; D C Rubinsztein; C Brayne
Journal:  Age Ageing       Date:  2009-11-24       Impact factor: 10.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.